Interstitial cystitis

The Urology Care Foundation Encourages Women to "Get up and Go" during Women's Health Month!

Retrieved on: 
Monday, May 3, 2021
Medical specialties, Surgery, Clinical medicine, Urology, Interstitial cystitis, Urinary bladder, Bladder cancer, William D. Steers, The Urology Foundation

The Urology Care Foundation, the world\'s leading nonprofit urological health foundation, utilizes the month of May to educate and raise awareness of urology-related conditions and diseases that mostly affect women like: overactive bladder, urinary tract infections, incontinence, interstitial cystitis and bladder cancer.

Key Points: 
  • The Urology Care Foundation, the world\'s leading nonprofit urological health foundation, utilizes the month of May to educate and raise awareness of urology-related conditions and diseases that mostly affect women like: overactive bladder, urinary tract infections, incontinence, interstitial cystitis and bladder cancer.
  • Women\'s Health Month is a call for women to take control of their own health," said Harris M. Nagler, MD, president of the Urology Care Foundation.
  • Our goal is to help women understand what steps they can take to improve not only their urologic health, but their overall health.
  • In addition, the Foundation will utilize Twitter, Facebook, Instagram, podcasts and more to disseminate information to promote a public dialogue and awareness around women\'s health issues.\nAbout the Urology Care Foundation:The Urology Care Foundation is the world\'s leading nonprofit urological health foundation, and the official foundation of the American Urological Association.

SPG's Danielle Mason Appointed to Elmiron MDL Leadership Team

Retrieved on: 
Tuesday, January 26, 2021
Medical specialties, Urology, Organ systems, Urinary bladder disorders, Infectious diseases, Martinotti, Interstitial cystitis, Pentosan polysulfate, Interstitial, Urinary tract infection, Urinary bladder

A federal judicial panel created the MDL in December 2020 and transferred nearly 130 Elmiron lawsuits to U.S. District Court for the District of New Jersey.

Key Points: 
  • A federal judicial panel created the MDL in December 2020 and transferred nearly 130 Elmiron lawsuits to U.S. District Court for the District of New Jersey.
  • Consumers allege that Elmiron, prescribed to treat a chronic bladder condition called interstitial cystitis, causes eye problems and vision loss.
  • The leadership team, which consists of eighteen women, follows directives from Judge Brian R. Martinotti to create a PSC reflecting significant inclusiveness and diversity.
  • "I'm honored to be appointed to this committee and to have the opportunity to work with such a talented and diverse leadership group," said Danielle.

MCI USA Welcomes New Full-Service Association Client National Association of Hispanic Nurses

Retrieved on: 
Tuesday, December 15, 2020
National Association of Hispanic Nurses, MCI, Interstitial cystitis, Medical specialties, Medicine, Clinical medicine

MCLEAN, Va., Dec. 15, 2020 /PRNewswire-PRWeb/ -- MCI USA 's Association Solutions division is pleased to welcome the National Association of Hispanic Nurses as a new full-service association management client.

Key Points: 
  • MCLEAN, Va., Dec. 15, 2020 /PRNewswire-PRWeb/ -- MCI USA 's Association Solutions division is pleased to welcome the National Association of Hispanic Nurses as a new full-service association management client.
  • With a membership in 47 local chapters, NAHN is the voice of over 276,000 Hispanic nurses across the United States.
  • "MCI USA is proud to welcome the National Association of Hispanic Nurses as a full-service management partner," said Erin M. Fuller, FASAE, CAE, President, Association Solutions, MCI USA.
  • MCI USA's healthcare clients include the Association for the Advancement of Wound Care, Association of Women Surgeons, and the Interstitial Cystitis Association (ICA).

Global Interstitial Cystitis Drugs Market to Have Positive Impact Due to COVID-19 Spread | $ 180 Million Incremental Growth During 2020-2024 | Technavio

Retrieved on: 
Wednesday, November 25, 2020
Health, Pharmaceutical, Medical specialties, Urinary bladder disorders, Organ systems, Clinical medicine, Interstitial cystitis, Interstitial, Urinary tract infection

View the full release here: https://www.businesswire.com/news/home/20201125005362/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20201125005362/en/
    Technavio has announced its latest market research report titled Global Interstitial Cystitis Drugs Market 2020-2024 (Graphic: Business Wire)
    Worried about the impact of COVID-19 on your Business?
  • The report on the interstitial cystitis drugs market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The market is driven by the high prevalence of interstitial cystitis, increasing awareness of interstitial cystitis, and increasing grants for research on interstitial cystitis.
  • This study identifies the advent of gene therapy as one of the prime reasons driving the interstitial cystitis drugs market growth during the next few years.

Napoli Shkolnik PLLC and Levy Konigsberg LLP File Elmiron Lawsuit Alleging Failure to Warn On Behalf of "Patient Zero" in Published Eye Injury Study

Retrieved on: 
Tuesday, June 9, 2020
Medical specialties, Organ systems, Medicine, RTT, Skeletal disorders, Urinary bladder disorders, Infectious diseases, Interstitial cystitis, Pentosan polysulfate, Urinary tract infection, Osteoarthritis, Pain

Elmiron is commonly prescribed for the treatment of the bladder pain associated with interstitial cystitis (IC) and is also prescribed, less frequently, for osteoarthritis.

Key Points: 
  • Elmiron is commonly prescribed for the treatment of the bladder pain associated with interstitial cystitis (IC) and is also prescribed, less frequently, for osteoarthritis.
  • Hull and five othersall of whom displayed the same unique eye injuries, but only shared one common medication: Elmiron.
  • In some studies, up to 24% percent of Elmiron users have been found to have the unique eye damage caused by Elmiron.
  • As advocates for victims and their families, plaintiff's advocates, we pledge the best of our experience, skill, and resources to every client.

Worldwide Interstitial Cystitis Industry to 2030 - Insights, Epidemiology and Market Forecast - ResearchAndMarkets.com

Retrieved on: 
Friday, June 5, 2020
Health, Pharmaceutical, Medical specialties, Urinary bladder disorders, Organ systems, Medicine, Interstitial cystitis, RTT, Infectious diseases, Interstitial, Ic, Urinary tract infection

The "Interstitial Cystitis (IC) - Market Insights, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Interstitial Cystitis (IC) - Market Insights, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This report delivers an in-depth understanding of the Interstitial Cystitis (IC), historical and forecasted epidemiology as well as the Interstitial Cystitis (IC) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
  • The Interstitial Cystitis (IC) market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM Interstitial Cystitis (IC) market size from 2017 to 2030.
  • The report also covers current Interstitial Cystitis (IC) treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.

Elmiron Lawsuit Filed by Johnson // Becker, PLLC Over Eye Damage and Vision Side Effects

Retrieved on: 
Friday, March 27, 2020
Health, Life sciences, Articles, Johnson & Johnson, Urinary bladder disorders, RTT, Janssen Pharmaceutica, Interstitial cystitis, Teva Pharmaceutical Industries, Pharmaceutical industry, Pentosan polysulfate

Johnson // Becker represents several individuals who allege they have suffered permanent vision loss after the use of the drug Elmiron, which is prescribed for the treatment of interstitial cystitis and bladder pain.

Key Points: 
  • Johnson // Becker represents several individuals who allege they have suffered permanent vision loss after the use of the drug Elmiron, which is prescribed for the treatment of interstitial cystitis and bladder pain.
  • Furthermore, they allege Janssen failed to properly warn patients and their physicians about the substantial eye damage and vision problems associated with the use of their drug Elmiron.
  • Teva Branded Pharmaceuticals is based in Pennsylvania while Janssen Pharmaceuticals, part of the Johnson & Johnson umbrella of companies, is a New Jersey-based company.
  • To learn more about Johnson // Becker and the Elmiron lawsuit, or to arrange a free, no-obligation case review, visit Johnson // Becker at https://www.johnsonbecker.com/drug-injuries/elmiron-lawsuit/ or contact the lawyers at (800) 279-6386.

Growth of Interstitial Cystitis Drugs Market to be impacted by the Advent of Gene Therapy | Technavio

Retrieved on: 
Friday, October 18, 2019
Health, Pharmaceutical, Medical specialties, Urology, Organ systems, Urinary bladder disorders, Infectious diseases, Interstitial cystitis, RTT, Interstitial, Urinary tract infection, Urinary bladder, Emphysematous cystitis, Urethral syndrome

Interstitial Cystitis Drugs Market Landscape 2019-2023: Geographic landscape

Key Points: 
  • Interstitial Cystitis Drugs Market Landscape 2019-2023: Geographic landscape
    Interstitial Cystitis Drugs Market Landscape 2019-2023: Type
    Register for a free trial today and gain instant access to 10,000+ market research reports.
  • Patients suffering from interstitial cystitis experience symptoms such as lower urinary tract issues and bladder pain.
  • The increasing number of interstitial cystitis cases is driving the demand for interstitial cystitis drugs.
  • Most of the interstitial cystitis drugs and off-label drugs are small molecules and have failed to fully cure the disease.

Georgia Urology's Dr. Jeffrey Proctor hosts ICA Walk for an IC Cure in Cartersville

Retrieved on: 
Friday, October 18, 2019
Urinary bladder disorders, Acworth, Interstitial cystitis, Ic, Interstitial, Cartersville, Georgia, Dellinger, Medical specialties, Medicine

CATERSVILLE, Ga., Oct. 18, 2019 /PRNewswire-PRWeb/ -- Georgia Urology's Dr. Jeffrey Proctor, an expert in the field of interstitial cystitis (IC), will be speaking at the ICA Walk for an IC Cure taking place Nov. 2 at Dellinger Park.

Key Points: 
  • CATERSVILLE, Ga., Oct. 18, 2019 /PRNewswire-PRWeb/ -- Georgia Urology's Dr. Jeffrey Proctor, an expert in the field of interstitial cystitis (IC), will be speaking at the ICA Walk for an IC Cure taking place Nov. 2 at Dellinger Park.
  • Dr. Proctor treats IC at Georgia Urology's Acworth and Cartersville locations.
  • "More than 12 million people in the US suffer from IC, and it can affect anyone," says Dr. Proctor.
  • Events such as the ICA Walk for an IC Cure will help get us there, one step at a time."

Antidiuretic Drugs: A Comprehensive Study of the World Market, 2019 to 2023 - ResearchAndMarkets.com

Retrieved on: 
Friday, April 5, 2019
Health, Pharmaceutical, Drugs, Medicine, Medical specialties, RTT, Nocturia, Urinary incontinence, Urinary bladder disorders, Polyuria, Antidiuretic, Interstitial cystitis, Ketamine, Urinary tract infection

The antidiuretic drugs market will register a CAGR of almost 10% by 2023.

Key Points: 
  • The antidiuretic drugs market will register a CAGR of almost 10% by 2023.
  • Furthermore, the high prevalence of conditions such as urinary incontinence and interstitial cystitis has been substantially contributing to the global antidiuretic drugs market.
  • Such a high prevalence of chronic conditions leads to polyuria and nocturia, which, in turn, will help in driving the global antidiuretic drugs market.
  • Hence, the disappointing results in drugs performance lead to the postponement of marketing approvals, which, further hampers the market growth.